Corifollitropin alfa

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCorifollitropin alfa
Drug Alias Name绒促卵泡素αcorifollitropine alfacorifollitropinum alfaLong-acting follicle-stimulating hormoneFollitropin-stimulating hormone long-acting +[14] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionFollicle-stimulating hormone receptor agonistsOvarian follicle stimulants
TargetsFollicle-stimulating hormone receptor
Therapy Area/IndicationsIdiopathie hypogonadotropic hypogonadismInfertility, FemaleAnovulation +[4] 
Global Approved IndicationsInfertility
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2010/01/25
Country/TerritoryMexicoRussian FederationSouth Africa +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN.V. OrganonSuzhou Genemen Biotech Co LtdXinlitai (Chengdu) Biological Technology Co Ltd
Inactive CompaniesNational And Kapodistrian University Of AthensOrganon & Co
Active IndicationsAnovulationInfertility
Inactive IndicationsIdiopathie hypogonadotropic hypogonadismInfertility, Female

Other Information

ATC CodeG03GA09
Related LinksWikipediaKEGG